Chronic pancreatitis is a putative risk factor for pancreatic cancer. The aim of this study was to examine the magnitude and temporality of this association. We searched MEDLINE and EMBASE for observational studies investigating the association between chronic pancreatitis and pancreatic cancer. We computed overall effect estimates (EEs) with associated 95% confi dence intervals (CIs) using a random-effects meta-analytic model. The EEs were stratifi ed by length of follow-up from chronic pancreatitis diagnosis to pancreatic cancer (lag period). Robustness of the results was examined in sensitivity analyses. We identifi ed 13 eligible studies. Pooled EEs for pancreatic cancer in patients with chronic pancreatitis were 16.16 (95% CI: 12.59-20.73) for patients diagnosed with pancreatic cancer within 2 years from their chronic pancreatitis diagnosis. The risk of pancreatic cancer in patients with chronic pancreatitis decreased when the lag period was increased to 5 years (EE: 7.90; 95% CI: 4.26-14.66) or a minimum of 9 years (EE: 3.53; 95% CI: 1.69-7.38). In conclusion, chronic pancreatitis increases the risk of pancreatic cancer, but the association diminishes with long-term follow-up. Five years after diagnosis, chronic pancreatitis patients have a nearly eight-fold increased risk of pancreatic cancer. We suggest that common practice on inducing a 2-year lag period in these studies may not be suffi cient. We also recommend a close follow-up in the fi rst years following a diagnosis of chronic pancreatitis to avoid overlooking a pancreatic cancer.
INTRODUCTION
Cancer of the pancreas is a major cause of cancer-related death in western countries ( 1 ) . It has a dismal prognosis mainly due to nonspecifi c symptoms at a time when curative intervention may be possible and a very aggressive tumor biology ( 2 ) . Th e 5-year survival rate has remained unchanged at approximately 5% throughout the past few decades ( 1, 3 ) . To prevent the occurrence of pancreatic cancer, more knowledge on preventable risk factors is needed.
Despite extensive research, there are only few recognized risk factors for pancreatic cancer such as exposure to tobacco smoking, heavy alcohol intake, and diabetes mellitus ( 4 ) . Chronic pancreatitis may also increase the risk of pancreatic cancer ( 5 ) . However, previous research is limited by potential misclassifi cation and possible confounding by tobacco smoking and alcohol consumption. Previously, this association was examined in two meta-analyses, both reporting a substantially increased risk ( 6, 7 ) . However, these meta-analyses included only a subset of the published work available at the time, and they lacked information on the temporality of the association between chronic pancreatitis and pancreatic cancer.
We therefore conducted a systematic review and meta-analysis of all observational studies to examine the association between chronic pancreatitis and pancreatic cancer with special emphasis on exploring the temporality of this association.
METHODS

Search strategy and inclusion criteria
We conducted a search for all eligible studies in MEDLINE and EMBASE on November 28, 2016 . In MEDLINE, we used the following search strings: ("Pancreatitis, Chronic" [Mesh] OR "Pancreatitis" [Mesh] OR "Pancreatitis, Alcoholic"[Mesh]) AND ("Pancreatic Neoplasms" [Mesh] OR "Neoplasms" [Mesh] ) and "Chronic pancreatitis AND pancreatic cancer". In EMBASE, we searched for ""pancreas cancer"/exp AND ("chronic pancreatitis"/ exp OR "alcoholic pancreatitis"/exp OR "pancreas calcifi cation"/ exp)" and ""chronic pancreatitis" AND "pancreas cancer"". No
Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis fi lters regarding study type, language, or time period was applied to the search. Th e literature search and reference screening was conducted by one medical doctor (J.K.). If the title was too ambiguous to allow exclusion, we reviewed the abstract and decided whether or not to include the study. Reference screening and study selection was performed using Covidence (Teamsquare, Melbourne, Australia).
We included all observational studies that (i) examined an association between chronic pancreatitis and subsequent pancreatic ductal adenocarcinoma (pancreatic cancer), and (ii) provided a relevant risk estimate in terms of odds ratio, rate ratio, standardized incidence ratio, or hazard ratio. We subsequently excluded papers that did not present full-texts in English, Danish, Swedish, or Norwegian and papers confi ned to patients with hereditary or tropical pancreatitis. Conference abstracts were ineligible for inclusion.
Data extraction
Data extraction was performed independently by two authors (J.K. and F.V.M.). For each study, we extracted descriptive information (author, year, journal, setting, recruitment methods and period, study design, sample size, and method of verifi cation of pancreatitis and pancreatic cancer), risk estimates with 95% confi dence interval (CI), and information on variables used for matching or adjustment. One study lacked the desired risk estimate, which was obtained aft er contact with the lead author ( 8 ) . Disagreements were settled by consensus.
Assessment of study quality and risk of bias
As there is no internationally agreed and properly validated quality score scale for use in reviews and meta-analyses, we used the "strengthening the reporting of observational studies in epidemio logy" (STROBE) guidelines as a template for assessment of each study ( 9 ) . We identifi ed key elements that could potentially introduce bias in the studies, including selection bias, information bias, and the possibility of unmeasured confounding.
Statistical analyses
Using the random-eff ects model of DerSimonian and Laird, we pooled the study specifi c risk estimates and calculated an overall eff ect estimate (EE) with associated 95% CI. Overall EEs are presented as forest plots. Risk estimates in terms of odds ratio, rate ratio, hazard ratio, and standardized incidence ratio were considered equivalent. We examined statistical heterogeneity using the I 2 statistic. To examine the temporality of the association between chronic pancreatitis and pancreatic cancer, we stratifi ed the analyses by the time from pancreatitis diagnosis to pancreatic cancer diagnosis (i.e., the lag period). Most studies induced either none, 1-year, or 2-year lag periods, and four studies provided estimates with 5-year lag periods. Only one study provided an estimate aft er 10 years of follow-up, whereas another study presented an estimate following a 9-year lag period. We therefore grouped these two studies together as a minimum 9-year lag period, providing a proxy for the long-term relationship. Sensitivity analyses were performed to examine the robustness of our results. We restricted to studies with more than 50 cancers or exposed subjects as a proxy for studies with high statistical precision, studies without self-reported or unverifi ed exposure or outcome, and studies with adjustment for tobacco exposure or alcohol consumption. Risk of publication bias was assessed using funnel plots and Egger's test. Statistical analyses were performed using Stata 13.1 (Stata Corp LP, College Station, TX, USA).
RESULTS
Literature search
In EMBASE and MEDLINE, we identifi ed 20,108 studies, of which 6,843 where duplicates and 13,110 were excluded based on the title. We screened the remaining 155 studies, excluding 148 papers for various reasons ( Figure 1 ). We identifi ed an additional six eligible studies through the reference lists of the reviewed papers. Th us, we included a total of 13 studies in this systematic review and meta-analysis.
Study characteristics and quality assessment
Among the 13 studies, four were case-control studies ( 8, (10) (11) (12) and nine were cohort studies ( 5, (13) (14) (15) (16) (17) (18) (19) (20) . Study characteristics are given in Tables 1 and 2 . Th e cohort studies included between 170 and 11,972 individuals. Six of the nine cohort studies observed fewer than 50 cases of pancreatic cancer. In the case-control studies, the number of cases ranged from 210 to 2,639, and no study included more than 100 pancreatic cancer patients with a history of chronic pancreatitis. In general, pancreatitis and pancreatic cancer diagnoses were verifi ed by clinical evaluation, the use of International Classifi cation of Diseases codes, or histology. One study lacked verifi cation of the cancer diagnosis ( 17 ) . In two case-control studies, diagnosis of pancreatitis was self-reported, leading to a risk of recall bias ( 8, 11 ) . In all but one cohort study ( 5 ) , which included a matched comparison cohort, standardization was used for adjustment. All cohort studies standardized by age, six studies standardized by sex (13) (14) (15) (16) 18, 20 ) , three studies by calendar year of diagnosis ( 13, 14, 17 ) , one study by district of residence ( 13 ), and one multicenter study by institution ( 15 ) . In all case-control studies, the controls were matched to the cases by age and sex, or multivariate analyses were adjusted for these covariates. Two of the 13 studies adjusted for tobacco smoking in their analyses ( 8, 11 ) . General limitations of the included studies consist of no or only a 1-year lag period from pancreatitis diagnosis to cancer, high risk of confounding by other risk factors such as smoking and alcohol, and risk of misclassifi cation of both exposure and outcome due to possible treatment outside the study setting. A more detailed list of the main risks of bias in each study is given in Supplementary Table 1 online .
Meta-analysis
Short-term risk . Th e pooled EE for pancreatic cancer among patients with chronic pancreatitis without any lag period between the two diagnoses was 7.96 (95% CI: 2.36-26.86). When restricting to studies with estimates for 1-or 2-year lag periods, our EEs were 6.09 (95% CI: 3.79-9.79) and 16.16 (95% CI: 12.59-20.73) respectively.
Long-term risk . Th e EE of pancreatic cancer among patients with chronic pancreatitis who were followed for 5 years from pancreatitis diagnosis was 7.90 (95% CI: 4.26-14.66). Th e risk decreased when increasing the follow-up period to at least 9 years (EE: 3.53; 95% CI: 1.69-7.38). Th e forest plot is depicted in Figure 2 .
Sensitivity analyses
In the fi rst sensitivity analysis, we omitted studies with <50 cancers (cohort studies) or 50 exposed cases (case-control studies) and 1 year of follow-up, yielding an EE of 6.09 (95% CI: 3.79-9.79). Further, when increasing this follow-up period to 5 years, the estimate decreased to 4.73 (95% CI: 3.44-6.50). When excluding studies with self-reported pancreatitis, unverifi ed pancreatic cancers, and less than a 2-year lag period between pancreatitis and cancer, the was 11.77 (95% CI: 6.88-20.12). In a fourth sensitivity analysis, we removed all studies with surgically treated chronic pancreatitis patients and <2 years of follow-up, which decreased the risk estimate (EE: 7.32; 95% CI: 3.18-16.83). When restricting to studies incorporating tobacco smoking in the multivariate model, the risk was decreased (EE: 2.94; 95% CI: 0.73-11.83). All EEs from the sensitivity analyses are presented as forest plots in the Supplementary Figures 1-4 .
Publication bias
Th e risk of publication bias was assessed using a funnel plot, which did not give rise to concerns about publication bias. Using the Egger test, we discovered no evidence of publication bias in any of the lag period groups.
DISCUSSION
In the present systematic review and meta-analysis, we found that patients with chronic pancreatitis are at an increased risk of pancreatic cancer compared with patients not aff ected by chronic pancreatitis. When excluding cancers occurring in the fi rst 2 years following a diagnosis of chronic pancreatitis, the risk of pancreatic cancer was elevated 16-fold. Although this risk declines over time, it persists even aft er long-term follow-up. Th e risk was still eightfold increased when introducing a 5-year lag period from pancreatitis diagnosis to pancreatic cancer diagnosis. Our fi ndings also suggest that patients with at least 9 years of follow-up from their pancreatitis diagnosis still had over three-fold increased risk of pancreatic cancer compared with patients without chronic pancreatitis.
Our observed short-term association between chronic pancreatitis and pancreatic cancer risk is most likely due to initial misclassifi cation of a pancreatic cancer as chronic pancreatitis. Th e risk of such misclassifi cation is high due to similarities in clinical, radiological, and biochemical nature of these diseases resulting in a complex diagnostic process ( 21 ) .
Th e long-term risk observed in the present study can have several explanations. First, detection bias may be present, as patients with chronic pancreatitis are frequently admitted to the hospital due to complications and comorbidity ( 5 ) . Second, results are likely to be confounded by tobacco exposure and alcohol consumption. Both are well-established risk factors for pancreatic cancer ( 4 ) and known to be more prevalent among chronic pancreatitis patients than the general population ( 22 ) . Th ird, a causal relationship may exist between chronic pancreatitis and pancreatic cancer. As infl ammation accumulates in the pancreas, pancreatic stellate cell activation may lead to carcinogenesis in genetically predisposed individuals ( 23 ) . In fact, around 90% of all pancreatic cancers harbor mutations in the K-ras oncogene ( 24 ) . In addition, K-ras mutations have been found in patients with chronic pancreatitis, indicating a common disease pathway ( 25 ) . Despite this, only around 5% of patients with chronic pancreatitis develop pancreatic cancer ( 6 ), and some chronic pancreatitis patients with K-ras mutations never develop pancreatic cancer ( 26 ) . Th e link between infl ammation and cancer observed in this study corresponds to evidence from other organs, in which infl ammation is known to increase the risk of cancer, for example in the colon ( 27 ) .
When inferring causality, time is an essential factor. Pancreatic cancer cases occurring <2 years aft er chronic pancreatitis diagnosis is unlikely to be caused by pancreatitis. Th us, in epidemiological studies of pancreatitis and pancreatic cancer, it is common practice to exclude patients diagnosed with pancreatic cancer within one or 2 years following a chronic pancreatitis. Of the included studies in this meta-analysis, only four studies provided risk estimates when excluding patients with <5 years of follow-up ( 5, 14, 15, 18 ) . Th e steep decrease in pancreatic cancer risk when comparing our 2-and 5-year EEs supports our hypothesis that pancreatic cancer may be initially misclassifi ed as chronic pancreatitis. Th e risk decrease also shows that a 2-year lag period may not be suffi cient to evaluate if a causal relationship exists in such studies. However, it should also be kept in mind that a lag-period from chronic pancreatitis symptoms to diagnosis can oft en last for many years. We recommend that future epidemiological studies on this topic should incorporate a longer lag-period, e.g., 5 years, from chronic pancreatitis to pancreatic cancer diagnosis to suffi ciently avoid the risk of initial misclassifi cation. precision. In three studies more than one-third of the patients were lost to follow-up ( 8, 11, 16 ) , and in one study, only 55% were males ( 17 ) , increasing the risk of selection bias. Although three studies included few patients with hereditary pancreatitis, no cancers were seen among these patients ( 16, 19, 20 ) , and this is therefore unlikely to explain our fi ndings. When interpreting results from our sensitivity analyses, it is important to keep in mind that the numbers included are small. Th us, conclusions drawn from these analyses should be cautious. Two meta-analyses have previously examined the association between chronic pancreatitis and pancreatic cancer, although both failed to include all available studies at that time. Raimondi et al. ( 6 ) , analyzed seven studies using a narrow search strategy (including only MeSH terms "Pancreatitis" and "Pancreatic Neoplasms" and searching only MEDLINE). Th ey provided risk estimates of 11.8 (95% CI: 5.8-24.1) and 5.8 (95% CI: 2.1-15.9) for 1-and 2-year lag periods respectively. However, they did not state which studies were included in these two models, limiting reproducibility and comparison. Further, they did not include a discussion in their paper. In a meta-analysis of six studies, Tong et al. ( 7 ) found an overall risk estimate of 10.35 (95% CI: 9.13-11.75). However, they included a study with unspecifi ed pancreatitis and a study on a diabetic population, resulting in a very heterogeneous population, which limits generalizability. Tong et al. also examined the To examine the eff ect of alcohol and tobacco smoking, we performed a sensitivity analysis, restricting to studies that adjusted for these risk factors. Th e association of chronic pancreatitis and pancreatic cancer risk was still three-fold increased, but the estimate had low precision. Four studies provided risk estimates for nonsmokers similar to those for smokers or stated that smoking did not have any impact on the estimate ( 15, (18) (19) (20) , whereas one study found an increased risk of pancreatic cancer among smokers ( 19 ) . Results were also disparate with regards to the eff ect of alcohol consumption, as one study found an increased risk among alcoholics ( 14 ) , which contrasts with fi ndings in another study ( 10 ) . Given the heterogeneity between studies, it is diffi cult to evaluate the impact of smoking and alcohol on the risk estimates. Based on the existing literature and knowledge of risk factors for pancreatic cancer, it is plausible that some proportion of the excess pancreatic cancer risk seen among patients with chronic pancreatitis may be due to residual confounding by alcohol and tobacco smoking.
We note considerable heterogeneity among the 13 studies included in this systematic review and meta-analysis. Also, some studies included only few cancers or few patients exposed to chronic pancreatitis, leading to infl ated risk estimates with low precision. Th is is also highlighted in our sensitivity analyses. When restricting the analyses to studies with more than 50 cancers or exposed subjects, EEs were more conservative and had higher temporality of the association with risk estimates of 2.82 (95% CI: 2.12-3.76) and 2.25 (95% CI: 1.59-3.19) for at least 5 and 10 years of follow-up, respectively, which are lower than our estimates. However, they included patients with both acute, chronic, and unspecifi ed pancreatitis in their analyses. Such potential misclassifi cation between acute and chronic may have underestimated the association, as acute pancreatitis is less likely than chronic pancreatitis to lead to pancreatic cancer ( 14 ) . Misclassifi cation of exposure is a general concern, as chronic pancreatitis can be very diffi cult to diagnose. In the present meta-analysis, most studies reported that chronic pancreatitis exposure was ascertained based on clinical evaluation and diagnostic criteria. Two studies included selfreported pancreatitis ( 8, 11 ) , four studies identifi ed patients based on International Classifi cation of Diseases codes with no information on the diagnostic process ( 5, 10, 13, 14 ) , and one study included patients from 1946 ( 15 ) , when diagnostic modalities were sparse, increasing the risk of misclassifi cation. Our study demonstrates that patients are at a substantially increased risk of pancreatic cancer following a diagnosis of chronic pancreatitis, especially in the fi rst few years aft er diagnosis. Our fi ndings may refl ect those of Munigala et al. ( 28 ) who suggested that ~5% of all pancreatic cancer patients were initially misdiagnosed as chronic pancreatitis, and a potential diagnostic delay of up to 2 years. As this delay compromises the chance of curative intent treatment, the clinical consequences of misdiagnosing pancreatic cancer as chronic pancreatitis are very high. Th erefore, clinicians should seek to conduct thorough examinations of patients with symptoms of chronic pancreatitis, and special awareness should be taken not to overlook a pancreatic cancer.
Although this misdiagnosis will likely decrease during the later years due to the increasing use of advanced diagnostic tools, the diff erential diagnostics between chronic pancreatitis and pancreatic cancer will likely represent a major clinical challenge for the coming years and should be subject for intensive investigation.
In conclusion, we found that patients with chronic pancreatitis have a markedly increased risk of pancreatic cancer. Th is risk declines over time, but it remains elevated almost 10 years aft er a diagnosis of chronic pancreatitis. Some of the excess risk may be due to exposure to tobacco smoking and alcohol consumption, detection bias, and initial misclassifi cation of cancer as pancreatitis. We suggest that the common practice to introduce a 2-year lag between chronic pancreatitis and pancreatic cancer diagnosis may not be suffi cient to avoid misclassifi cation, and we recommend a close follow-up of patients following a chronic pancreatitis diagnosis.
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